Important Notice!

This platform will close permanently on 21 December 2026. Please complete all courses and download all certificates before that date.

About This Course

This course has been designed to provide doctors and other relevant healthcare professionals with a practical overview of the management of juvenile idiopathic arthritis with interleukin-6 receptor inhibition therapy, with a specific focus on tocilizumab and its biosimilars. This course should take approximately 60 minutes to complete.

This course has a 2-year expiry date of 29th July, 2026. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.

CME/CPD Information

This course has been accredited by the European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) with 1 European CME credit (ECMEC®). This accreditation certifies the quality and relevance of the educational content.

The logo of the European Accreditation Council for Continuing Medical Education

Learning Outcomes

By the end of this course, you should be able to:

  • list the symptoms of juvenile idiopathic arthritis (JIA) (specifically, systemic JIA and polyarticular JIA) and describe its impact on children and their families.

  • explain the mechanism of action of interleukin-6 receptor (IL-6R) inhibitors and their biosimilars.

  • explain the place of IL-6R inhibitors and their biosimilars in the management of JIA subtypes, particularly systemic JIA and polyarticular JIA, and JIA-associated uveitis.

  • identify the right patients for anti-IL-6R therapy.

Expert Faculty

This course has been made in close collaboration with:

Expert Faculty

Course curriculum

    1. Welcome to the Course

    1. Introduction to Precourse Quiz

    2. Precourse Quiz

    1. Introduction to Juvenile Idiopathic Arthritis

    1. The Role of Interleukin-6 in Juvenile Idiopathic Arthritis

    1. Interleukin-6 Receptor Inhibition in sJIA

    1. Interleukin-6 Receptor Inhibition in pJIA

    1. IL-6R Inhibition in JIA-Associated Uveitis

    1. Introduction to Final Quiz

    2. Final Quiz

    1. Conclusions and Take-Home Messages

    2. Course Feedback Survey

    3. Funding

About this course

  • Free
  • 13 lessons
  • 0 hours of video content
Certificate
Multimedia
Text
Survey
Quiz
FREE
Enroll course